Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
115.91
-1.57 (-1.34%)
May 8, 2025, 4:00 PM EDT - Market closed
Encompass Health Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Encompass Health stock have an average target of 119.5, with a low estimate of 100 and a high estimate of 135. The average target predicts an increase of 3.10% from the current stock price of 115.91.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Encompass Health stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $117 → $130 | Strong Buy | Maintains | $117 → $130 | +12.16% | Apr 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $110 → $125 | Buy | Maintains | $110 → $125 | +7.84% | Apr 28, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $116 → $135 | Strong Buy | Reiterates | $116 → $135 | +16.47% | Apr 28, 2025 |
| Keybanc | Keybanc | Buy Maintains $120 → $122 | Buy | Maintains | $120 → $122 | +5.25% | Apr 25, 2025 |
| Barclays | Barclays | Buy Maintains $118 → $129 | Buy | Maintains | $118 → $129 | +11.29% | Apr 25, 2025 |
Financial Forecast
Revenue This Year
5.92B
from 5.37B
Increased by 10.10%
Revenue Next Year
6.43B
from 5.92B
Increased by 8.65%
EPS This Year
4.85
from 4.46
Increased by 8.86%
EPS Next Year
5.39
from 4.85
Increased by 10.99%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.2B | 6.8B | 7.4B | |
| Avg | 5.9B | 6.4B | 7.0B | |
| Low | 5.7B | 6.2B | 6.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 15.0% | 14.5% | 14.9% | |
| Avg | 10.1% | 8.7% | 8.1% | |
| Low | 6.2% | 4.1% | 3.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 5.15 | 6.01 | 6.73 | |
| Avg | 4.85 | 5.39 | 5.94 | |
| Low | 4.58 | 4.91 | 5.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 15.4% | 23.7% | 24.9% | |
| Avg | 8.9% | 11.0% | 10.2% | |
| Low | 2.6% | 1.2% | -4.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.